Pembrolizumab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC.

Diaz, LA; Marabelle, A; Delord, JP; Shapira-Frommer, R; Geva, R; Peled, N; Kim, TW; Andre, T; Van Cutsenn, E; Guimbaud, R; Jaeger, D; Elez, E; Yoshino, T; Joe, AK; Lam, B; Gause, CK; Pruitt, SK; Kang, SP; Le, DT

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):